Canopy Growth Corporation (CGC)

$4.48

-0.26

(-5.49%)▲

Market is closed - opens 7 PM, 09 Sep 2024

Performance

  • $4.44
    $4.75
    $4.48
    downward going graph

    0.85%

    Downside

    Day's Volatility :6.48%

    Upside

    5.68%

    downward going graph
  • $0.51
    $19.20
    $4.48
    downward going graph

    88.51%

    Downside

    52 Weeks Volatility :97.32%

    Upside

    76.67%

    downward going graph

Returns

PeriodCanopy Growth CorporationSector (Health Care)Index (Russel 2000)
3 Months
-36.27%
5.1%
0.0%
6 Months
50.84%
4.9%
0.0%
1 Year
-41.05%
16.6%
0.0%
3 Years
-97.34%
13.2%
-22.3%

Highlights

Market Capitalization
527.8M
Book Value
$6.58
Earnings Per Share (EPS)
-5.84
Wall Street Target Price
4.28
Profit Margin
-259.94%
Operating Margin TTM
-32.19%
Return On Assets TTM
-3.83%
Return On Equity TTM
-87.26%
Revenue TTM
287.1M
Revenue Per Share TTM
3.55
Quarterly Revenue Growth YOY
-13.200000000000001%
Gross Profit TTM
-81.9M
EBITDA
-59.4M
Diluted Eps TTM
-5.84
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-4.21
EPS Estimate Next Year
-0.94
EPS Estimate Current Quarter
-0.34
EPS Estimate Next Quarter
-0.3

Analyst Recommendation

Sell
    5%Buy
    45%Hold
    50%Sell
Based on 20 Wall street analysts offering stock ratings for Canopy Growth Corporation(by analysts ranked 0 to 5 stars)
Based on 20 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
1
1
1
Hold
9
9
9
Sell
10
10
10

Analyst Forecast

What analysts predicted

Downside of 4.46%

Current $4.48
Target $4.28

Company Financials

FY19Y/Y Change
Revenue
169.5M
↑ 190.37%
Net Income
-501.7M
↑ 1137.84%
Net Profit Margin
-296.06%
↓ 226.61%
FY20Y/Y Change
Revenue
286.5M
↑ 76.18%
Net Income
-996.8M
↑ 107.05%
Net Profit Margin
-347.93%
↓ 51.87%
FY21Y/Y Change
Revenue
434.8M
↑ 37.08%
Net Income
-1.3B
↑ 20.42%
Net Profit Margin
-305.65%
↑ 42.28%
FY22Y/Y Change
Revenue
411.2M
↓ 4.82%
Net Income
-253.3M
↓ 80.82%
Net Profit Margin
-61.59%
↑ 244.06%
FY23Y/Y Change
Revenue
294.3M
↓ 22.57%
Net Income
-2.4B
↑ 932.67%
Net Profit Margin
-821.42%
↓ 759.83%
FY24Y/Y Change
Revenue
219.5M
↓ 26.25%
Net Income
-485.5M
↓ 80.14%
Net Profit Margin
-221.19%
↑ 600.23%
Q1 FY23Q/Q Change
Revenue
63.9M
↓ 13.51%
Net Income
-473.0M
↑ 142.8%
Net Profit Margin
-739.83%
↓ 476.3%
Q2 FY23Q/Q Change
Revenue
81.8M
↑ 24.21%
Net Income
-28.7M
↓ 94.11%
Net Profit Margin
-35.06%
↑ 704.77%
Q3 FY23Q/Q Change
Revenue
60.6M
↓ 24.51%
Net Income
-228.8M
↑ 713.24%
Net Profit Margin
-377.72%
↓ 342.66%
Q4 FY23Q/Q Change
Revenue
58.5M
↓ 4.35%
Net Income
-161.6M
↓ 30.07%
Net Profit Margin
-276.16%
↑ 101.56%
Q1 FY24Q/Q Change
Revenue
39.7M
↓ 31.56%
Net Income
-50.3M
↓ 68.56%
Net Profit Margin
-126.86%
↑ 149.3%
Q2 FY24Q/Q Change
Revenue
35.3M
↓ 9.96%
Net Income
-67.8M
↑ 36.29%
Net Profit Margin
-192.02%
↓ 65.16%
FY19Y/Y Change
Total Assets
6.5B
↑ 507.72%
Total Liabilities
1.1B
↑ 669.9%
FY20Y/Y Change
Total Assets
4.9B
↓ 21.46%
Total Liabilities
1.2B
↑ 12.72%
FY21Y/Y Change
Total Assets
5.4B
↓ 0.5%
Total Liabilities
2.5B
↑ 90.59%
FY22Y/Y Change
Total Assets
4.4B
↓ 17.71%
Total Liabilities
1.6B
↓ 38.01%
FY23Y/Y Change
Total Assets
1.8B
↓ 56.56%
Total Liabilities
1.2B
↓ 15.39%
FY24Y/Y Change
Total Assets
960.5M
↓ 46.69%
Total Liabilities
590.8M
↓ 52.37%
Q1 FY23Q/Q Change
Total Assets
1.8B
↓ 19.24%
Total Liabilities
1.2B
↑ 6.24%
Q2 FY23Q/Q Change
Total Assets
1.6B
↓ 10.19%
Total Liabilities
1.0B
↓ 20.01%
Q3 FY23Q/Q Change
Total Assets
1.2B
↓ 23.84%
Total Liabilities
678.2M
↓ 31.59%
Q4 FY23Q/Q Change
Total Assets
1.0B
↓ 18.49%
Total Liabilities
607.6M
↓ 11.28%
Q1 FY24Q/Q Change
Total Assets
709.0M
↓ 29.41%
Total Liabilities
436.1M
↓ 27.56%
Q2 FY24Q/Q Change
Total Assets
685.9M
↓ 2.09%
Total Liabilities
401.7M
↓ 6.77%
FY19Y/Y Change
Operating Cash Flow
-389.7M
↑ 538.62%
Investing Cash Flow
-2.4B
↑ 1343.75%
Financing Cash Flow
4.4B
↑ 1010.05%
FY20Y/Y Change
Operating Cash Flow
-555.1M
↑ 48.44%
Investing Cash Flow
-249.8M
↓ 89.23%
Financing Cash Flow
-41.1M
↓ 100.98%
FY21Y/Y Change
Operating Cash Flow
-370.4M
↓ 39.72%
Investing Cash Flow
-703.1M
↑ 154.31%
Financing Cash Flow
1.0B
↓ 2312.64%
FY22Y/Y Change
Operating Cash Flow
-431.3M
↑ 17.19%
Investing Cash Flow
182.4M
↓ 126.11%
Financing Cash Flow
-36.0M
↓ 103.6%
Q1 FY23Q/Q Change
Operating Cash Flow
-102.1M
↓ 2.89%
Investing Cash Flow
104.1M
↑ 5.51%
Financing Cash Flow
92.2M
↓ 194.55%
Q2 FY23Q/Q Change
Operating Cash Flow
-111.9M
↑ 6.39%
Investing Cash Flow
107.3M
↑ 0.0%
Financing Cash Flow
-100.2M
↓ 205.45%

Technicals Summary

Sell

Neutral

Buy

Canopy Growth Corporation is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Canopy Growth Corporation
Canopy Growth Corporation
-29.89%
50.84%
-41.05%
-97.34%
-98.35%
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
-16.62%
-11.2%
10.78%
28.21%
20.17%
Haleon Plc Spon Ads
Haleon Plc Spon Ads
7.49%
20.82%
28.48%
39.41%
39.41%
Zoetis Inc.
Zoetis Inc.
2.41%
4.25%
0.77%
-8.94%
49.4%
Viatris Inc.
Viatris Inc.
-0.79%
-8.6%
12.7%
-23.12%
-31.03%
Catalent, Inc.
Catalent, Inc.
0.82%
6.48%
22.57%
-57.47%
16.16%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Canopy Growth Corporation
Canopy Growth Corporation
NA
NA
NA
-4.21
-0.87
-0.04
NA
6.58
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
36.53
36.53
0.27
4.57
0.16
0.12
NA
24.87
Haleon Plc Spon Ads
Haleon Plc Spon Ads
33.32
33.32
1.47
0.39
0.07
0.04
0.02
1.82
Zoetis Inc.
Zoetis Inc.
36.6
36.6
2.61
5.82
0.49
0.14
0.01
10.94
Viatris Inc.
Viatris Inc.
224.4
NA
0.07
2.68
-0.03
0.03
0.04
16.36
Catalent, Inc.
Catalent, Inc.
211.02
NA
2.87
0.2
-0.25
0.0
NA
19.91
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Canopy Growth Corporation
Canopy Growth Corporation
Sell
$527.8M
-98.35%
NA
-259.94%
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
Buy
$12.2B
20.17%
36.53
16.0%
Haleon Plc Spon Ads
Haleon Plc Spon Ads
Buy
$47.1B
39.41%
33.32
9.66%
Zoetis Inc.
Zoetis Inc.
Buy
$85.7B
49.4%
36.6
26.29%
Viatris Inc.
Viatris Inc.
Hold
$13.5B
-31.03%
224.4
-4.24%
Catalent, Inc.
Catalent, Inc.
Hold
$10.9B
16.16%
211.02
-23.81%

Insights on Canopy Growth Corporation

  • Decreasing Revenue

    Revenue is down for the last 5 quarters, 108.72M → 48.38M (in $), with an average decrease of 17.6% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -68.16M → -92.89M (in $), with an average decrease of 36.3% per quarter

  • Vs HLN

    In the last 1 year, Haleon Plc Spon Ads has given 28.5% return, outperforming this stock by 69.6%

Institutional Holdings

  • Tidal Investments LLC.

    2.54%

  • Morgan Stanley - Brokerage Accounts

    0.69%

  • Two Sigma Investments LLC

    0.45%

  • Bank of America Corp

    0.42%

  • Ameriprise Financial Inc

    0.28%

  • Two Sigma Advisers, LLC

    0.26%

Company Information

canopy growth corporation is a world-leading diversified cannabis company. we operate a collection of diverse brands and curated strain variety, supported millions of square feet of indoor greenhouse production capacity, partnered with some of the leading names in the sector. here's to future growth.

Organization
Canopy Growth Corporation
Employees
1029
CEO
Mr. David Eric Klein
Industry
Process Industries

Discover More

FAQs